GlassScriptPhysician profile
Ariane Abadi
NPI 1619641685
$1,243.00
in general payments reported to CMS, 2019-2025
11 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $547 · 2024: $289 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $317.45 | 2023-2025 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $163.70 | 2023-2025 | Camzyos, Eliquis |
| Bridgebio Pharma, INC. | $150.00 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $120.35 | 2024 | Wainua |
| Merck Sharp & Dohme LLC | $119.52 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.34 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.75 | 2024 | Jardiance |
| Pfizer INC. | $57.61 | 2025 | |
| Alnylam Pharmaceuticals INC. | $52.14 | 2025 | Onpattro |
| Novo Nordisk INC | $22.59 | 2024 | |
| Scpharmaceuticals INC. | $14.55 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariane Abadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.